Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET).
In utero
Nonhuman primate
Positron emission tomography
SV2A
Synaptogenesis
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
20
12
2021
accepted:
26
04
2022
pubmed:
29
5
2022
medline:
26
8
2022
entrez:
28
5
2022
Statut:
ppublish
Résumé
Exploring synaptic density changes during brain growth is crucial to understanding brain development. Previous studies in nonhuman primates report a rapid increase in synapse number between the late gestational period and the early neonatal period, such that synaptic density approaches adult levels by birth. Prenatal synaptic development may have an enduring impact on postnatal brain development, but precisely how synaptic density changes in utero are unknown because current methods to quantify synaptic density are invasive and require post-mortem brain tissue. We used synaptic vesicle glycoprotein 2A (SV2A) positron emission tomography (PET) radioligands [ Image-derived fetal brain SV2A measures increased during the third trimester. SV2A concentrations were greater in subcortical regions than in cortical regions at both gestational ages. Near term, SV2A density was higher in primary motor and visual areas than respective associative regions. Post-mortem quantification of SV2A density was significantly correlated with regional SV2A PET measures. While further study is needed to determine the exact relationship of SV2A and synaptic density, the imaging paradigm developed in the current study allows for the effective in vivo study of SV2A development in the fetal brain.
Identifiants
pubmed: 35633376
doi: 10.1007/s00259-022-05825-6
pii: 10.1007/s00259-022-05825-6
pmc: PMC9826644
mid: NIHMS1845163
doi:
Substances chimiques
Membrane Glycoproteins
0
Nerve Tissue Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3679-3691Subventions
Organisme : NIH HHS
ID : S10 OD016261
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIH HHS
ID : P51 OD011107
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH120615
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR025063
Pays : United States
Organisme : NHLBI NIH HHS
ID : R24 HL085794
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR029245
Pays : United States
Organisme : NIH HHS
ID : U42 OD027094
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Science. 1986 Apr 11;232(4747):232-5
pubmed: 3952506
Schizophr Res. 2016 Nov;177(1-3):3-9
pubmed: 26972474
J Nucl Med. 2003 Sep;44(9):1522-30
pubmed: 12960202
J Vis Exp. 2017 Oct 6;(128):
pubmed: 29053699
Brain Res. 1979 Mar 16;163(2):195-205
pubmed: 427544
Brain Res. 2019 Jul 15;1715:73-83
pubmed: 30905653
Schizophr Bull. 2014 Sep;40(5):952-7
pubmed: 25053651
ACS Chem Neurosci. 2019 Mar 20;10(3):1544-1554
pubmed: 30396272
Science. 1986 Feb 21;231(4740):840-3
pubmed: 3945811
Int J Dev Neurosci. 1989;7(6):581-9
pubmed: 2603756
J Nucl Med. 2020 Mar;61(3):453-460
pubmed: 31562219
Psychoneuroendocrinology. 2002 Jan-Feb;27(1-2):285-98
pubmed: 11750784
J Neurosci Res. 1999 May 1;56(3):307-15
pubmed: 10336260
Alzheimers Dement. 2020 Jul;16(7):974-982
pubmed: 32400950
J Cereb Blood Flow Metab. 2020 Sep;40(9):1890-1901
pubmed: 31570041
Arch Gen Psychiatry. 1987 Jul;44(7):660-9
pubmed: 3606332
J Comp Neurol. 1997 Oct 20;387(2):167-78
pubmed: 9336221
Neuroscience. 2001;105(1):7-17
pubmed: 11483296
Proc Natl Acad Sci U S A. 1989 Jun;86(11):4297-301
pubmed: 2726773
Cereb Cortex. 2021 Mar 31;31(5):2309-2321
pubmed: 33341889
Schizophr Bull. 1992;18(2):319-32
pubmed: 1377834
BMC Neurosci. 2013 Aug 09;14:87
pubmed: 23937191
J Neurocytol. 1983 Aug;12(4):697-712
pubmed: 6619907
J Cereb Blood Flow Metab. 2021 May;41(5):1067-1079
pubmed: 32757741
J Comput Assist Tomogr. 1979 Jun;3(3):299-308
pubmed: 438372
J Nucl Med. 2016 May;57(5):777-84
pubmed: 26848175
Front Neurosci. 2017 Feb 02;11:29
pubmed: 28210206
J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
pubmed: 8784228
Brain Res Bull. 2010 Jan 15;81(1):107-13
pubmed: 19751806
Neuroimage. 2021 May 15;232:117877
pubmed: 33639258
J Neurosci. 1993 Jul;13(7):2801-20
pubmed: 8331373
J Comp Neurol. 1972 May;145(1):61-83
pubmed: 4624784
Brain Res Dev Brain Res. 1989 Nov 1;50(1):11-32
pubmed: 2582602
Nat Commun. 2019 Apr 4;10(1):1529
pubmed: 30948709
Ann Neurol. 1987 Oct;22(4):487-97
pubmed: 3501693
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15268-73
pubmed: 10611374
Sci Transl Med. 2016 Jul 20;8(348):348ra96
pubmed: 27440727
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1582-7
pubmed: 20080687
Cell. 2006 Nov 17;127(4):831-46
pubmed: 17110340
Neurosci Lett. 1982 Dec 13;33(3):247-52
pubmed: 7162689
J Neurosci. 2011 Jan 26;31(4):1461-70
pubmed: 21273430
Cereb Cortex. 2017 Sep 1;27(9):4463-4477
pubmed: 27566980
J Nucl Med. 2018 Jun;59(6):993-998
pubmed: 29419483
Science. 1992 Aug 28;257(5074):1271-3
pubmed: 1519064
Epilepsia. 2020 Oct;61(10):2183-2193
pubmed: 32944949
J Cereb Blood Flow Metab. 2010 Aug;30(8):1437-40
pubmed: 20531464
JAMA Neurol. 2018 Oct 1;75(10):1215-1224
pubmed: 30014145
Neuropsychopharmacology. 2010 Jan;35(1):147-68
pubmed: 19794405
Cereb Cortex. 1991 Nov-Dec;1(6):510-23
pubmed: 1822755